RN
Rina Nag
About Rina Nag
Data last updated:
Rina Nag is a Director at Lorfan Pharma Private Limited (since 2024). Lorfan Pharma Private Limited reported revenue of ₹27.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lorfan Pharma Private Limited U47721WB2024PTC267243 | Director | 02 Jan 2024 | 2024 | ₹27.1 Lakh (FY 2025) | Active |
Board colleagues of Rina Nag
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manali Ghosh | 10449835 | Lorfan Pharma Private Limited | Director |
| Sabari Mondal | 11490227 | Lorfan Pharma Private Limited | Additional Director |
| Soma Banerjee | 10601554 | Lorfan Pharma Private Limited | Additional Director |
| Suparna Nag Rajak | 10449837 | Lorfan Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rina Nag
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rina Nag
Rina Nag currently holds 1 directorship: Lorfan Pharma Private Limited (Director, since 02 Jan 2024, revenue ₹27.1 Lakh (FY 2025)).
Rina Nag was first appointed on 02 Jan 2024 as Director at Lorfan Pharma Private Limited.
The current boards of Rina Nag's companies include Manali Ghosh (Lorfan Pharma Private Limited), Sabari Mondal (Lorfan Pharma Private Limited), Soma Banerjee (Lorfan Pharma Private Limited), Suparna Nag Rajak (Lorfan Pharma Private Limited).